Figure 2
From: Validation of plasma microRNAs as biomarkers for myotonic dystrophy type 1

miR-133b validation as DM1 biomarker.
(a) Box plot of miR-133b levels in the plasma of DM1 and controls (CTR; ****pā<ā0.0001). (b) ROC curve illustrating sensitivity and specificity of plasma miR-133b in discriminating healthy from diseased patients. (c) Spearmanās inverse correlation between miRNA-133b fold change compared to CTR and muscle strength measured by MRC megascore. (d) Spearmanās direct correlation between miRNA-133b fold change compared to CTR and CK plasma levels. For all panels, DM1 nā=ā103, CTR nā=ā111.